Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers Academic Article uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Estrogen Replacement Therapy
  • Genes, BRCA1
  • Mutation
  • Postmenopause

abstract

  • Among postmenopausal women with a BRCA1 mutation, HT use was not associated with increased risk of breast cancer; indeed, in this population, it was associated with a decreased risk.

authors

publication date

  • October 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2556701

Digital Object Identifier (DOI)

  • 10.1093/jnci/djn313

PubMed ID

  • 18812548

Additional Document Info

start page

  • 1361

end page

  • 7

volume

  • 100

number

  • 19